Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28468317 | 1.00 | ALDH1A1 (0.42) | ALDH1A1POLBTDP1CYP1A2KMT2A | |
| SCHEMBL145307 | 1.00 | — | — | |
| SCHEMBL9079929 | 1.00 | ALDH1A1 (0.42) | ALDH1A1POLBTDP1CYP1A2KMT2A | |
| SCHEMBL28497988 | 0.96 | ALDH1A1 (0.40) | ALDH1A1POLBTDP1CYP1A2KMT2A | |
| Hydrochloric Acid SCHEMBL10787986 | 0.96 | ALDH1A1 (0.40) | ALDH1A1POLBTDP1CYP1A2KMT2A | |
| SCHEMBL21809205 | 0.89 | ALDH1A1 (0.55) | ALDH1A1KMT2AMEN1USP2LMNA | |
| SCHEMBL27087746 | 0.87 | ALDH1A1 (0.35) | ALDH1A1POLBTDP1CYP1A2KMT2A | |
| SCHEMBL76824 | 0.85 | — | — | |
| SCHEMBL153114 | 0.85 | — | — | |
| SCHEMBL31156371 | 0.85 | ALDH1A1 (0.38) | ALDH1A1POLBTDP1CYP1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243089-A1 | NOVEL MAGNETIC METAL ORGANIC FRAMEWORK MATERIAL FOR BARIUM COLLECTION FROM PRODUCED WATER | SAUDI ARABIAN OIL COMPANY (SA) | 2025-07-31 | — | — | US | claimed |
| CN-119752387-A | Aldehyde-free polyurethane adhesive for high-conductivity leather products containing imidazole heterocycle ionic liquid and preparation method thereof | 广东菲安妮皮具股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-118807489-A | Reduced graphene oxide/covalent organic framework nanofiltration membrane and preparation method thereof | 江南大学 | 2024-10-22 | — | — | CN | claimed |
| CN-118253352-A | Preparation method and application of hemp rope type COF wrapped heteropolyoxometalate oxidation desulfurization catalyst | 山东大学 | 2024-06-28 | — | — | CN | claimed |
| CN-117447472-A | Synthesis method of 2, 4-diamino-6-chloromethyl pteridine | 南京远淑医药科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116457084-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-108719645-B | Creep feed mate | 宁波科瑞特动物药业有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-105777381-B | Vitamin B-containing medium-trace element compound fertilizer and preparation method thereof | 河南捷农生化有限公司 | 2020-03-24 | — | — | CN | claimed |
| US-20170112829-A1 | USE OF COMPOUNDS BINDING TO THE SIGMA RECEPTOR LIGANDS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2017-04-27 | — | — | US | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20090042898-A1 | USE OF COMPOUNDS ACTIVE ON THE SIGMA RECEPTOR FOR THE TREATMENT OF MECANICAL ALLODYNIA | LABORATORIOS DEL DR. ESTEVE S.A. (ES) | 2009-02-12 | — | — | US | claimed |
| CN-1602191-A | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase | NOVO NORDISK AS (DK) | 2005-03-30 | — | — | CN | claimed |
| EP-0471592-B1 | Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids | DOW CHEMICAL CO (US) | 1995-08-09 | — | — | EP | claimed |
| EP-0552360-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-07-28 | — | — | EP | claimed |
| WO-1993003825-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-03-04 | — | — | WO | claimed |
| US-5167941-A | Sulfur dioxide; cationic polyelectrolyte stabilizers | THE DOW CHEMICAL COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| US-5098681-A | Piperaznes having carbonyl groups | THE DOW CHEMICAL COMPANY (US) | 1992-03-24 | — | — | US | claimed |
| EP-0471592-A2 | Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids | THE DOW CHEMICAL COMPANY (US) | 1992-02-19 | — | — | EP | claimed |
| EP-0084162-B1 | VULCANIZABLE EPOXIDE-CONTAINING ETHYLENE COPOLYMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-09-23 | — | — | EP | claimed |
| EP-0084162-A2 | Vulcanizable epoxide-containing ethylene copolymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-07-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042898-A1 | USE OF COMPOUNDS ACTIVE ON THE SIGMA RECEPTOR FOR THE TREATMENT OF MECANICAL ALLODYNIA | OPRM1, OPRL1, OPRK1 | ALDH1A1 2758/4885POLB 1844/4885TDP1 3956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.